MedTrace Logo

The Effects of Lactobacillus Rhamnosus (JB-1) on Stress and Cognition

NCT03160066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2017-05-30

No results posted yet for this study

Summary

Emerging evidence suggests that microorganisms acting via the Brain-Gut axis may have potential benefits for the management of stress-related conditions. The majority of studies have focused on animal models. Preclinical studies have identified the Lactobacillus Rhamnosus JB-1 strain as a putative psychobiotic with an impact on stress-related behaviours, physiology and cognitive performance. Whether such preclinical effects could be translated to healthy human volunteers remains unknown.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Lactobacillus Rhamnosus (JB-1)

Lactobacillus Rhamnosus (JB-1) capsule

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Ted Dinan, MD, PhD · University College Cork

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160066 on ClinicalTrials.gov